AU8536398A - Incorporation of pharmacologically active amino acid analogues into proteins - Google Patents
Incorporation of pharmacologically active amino acid analogues into proteinsInfo
- Publication number
- AU8536398A AU8536398A AU85363/98A AU8536398A AU8536398A AU 8536398 A AU8536398 A AU 8536398A AU 85363/98 A AU85363/98 A AU 85363/98A AU 8536398 A AU8536398 A AU 8536398A AU 8536398 A AU8536398 A AU 8536398A
- Authority
- AU
- Australia
- Prior art keywords
- incorporation
- proteins
- amino acid
- pharmacologically active
- acid analogues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19724670A DE19724670A1 (en) | 1997-06-11 | 1997-06-11 | Incorporation of pharmacologically active amino acid analogs into proteins |
| DE19724670 | 1997-06-11 | ||
| PCT/EP1998/003398 WO1998056824A2 (en) | 1997-06-11 | 1998-06-05 | Incorporation of pharmacologically active amino acid analogues into proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8536398A true AU8536398A (en) | 1998-12-30 |
Family
ID=7832171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU85363/98A Abandoned AU8536398A (en) | 1997-06-11 | 1998-06-05 | Incorporation of pharmacologically active amino acid analogues into proteins |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0998487A2 (en) |
| AU (1) | AU8536398A (en) |
| DE (1) | DE19724670A1 (en) |
| WO (1) | WO1998056824A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10255132A1 (en) * | 2002-11-26 | 2004-07-15 | Max Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Composition containing peptide that includes amino acid analog, useful for treating e.g. cancer, where the peptide binds to and enters only specific target cells |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061693A (en) * | 1989-07-28 | 1991-10-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| NL9200481A (en) * | 1992-03-13 | 1993-10-01 | Univ Groningen | PHARMACEUTICAL PREPARATION WITH PLACE-ORIENTED DELIVERY. |
| JPH0940577A (en) * | 1995-05-24 | 1997-02-10 | Mitsui Toatsu Chem Inc | Pharmaceutical composition containing tripeptide and dipeptide |
-
1997
- 1997-06-11 DE DE19724670A patent/DE19724670A1/en not_active Ceased
-
1998
- 1998-06-05 WO PCT/EP1998/003398 patent/WO1998056824A2/en not_active Ceased
- 1998-06-05 AU AU85363/98A patent/AU8536398A/en not_active Abandoned
- 1998-06-05 EP EP98936310A patent/EP0998487A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE19724670A1 (en) | 1998-12-24 |
| WO1998056824A3 (en) | 1999-04-08 |
| WO1998056824A2 (en) | 1998-12-17 |
| EP0998487A2 (en) | 2000-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5420499A (en) | Novel aryl sulphonamide amino acid esters and analogues | |
| AU3574897A (en) | Aqueous formulations of peptides | |
| AU2484399A (en) | Controlled release delivery of peptide or protein | |
| AU8166098A (en) | Removal of biologically active agents | |
| AU6883298A (en) | An engineered seed protein having a higher percentage of essential amino acids | |
| ZA9811327B (en) | Compositions and methods for altering amino acid content of proteins | |
| PL335974A1 (en) | Method of orally administering proteins | |
| ZA989740B (en) | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents | |
| AU3826899A (en) | Peptide analogues of pacap | |
| AU3321595A (en) | Recombinant production of biologically active peptides and proteins | |
| AU2548097A (en) | Formulations of ob protein | |
| AU2091799A (en) | Uses of alpha-conotoxin peptides | |
| AU7758598A (en) | Stable pharmaceutical administration forms of peptides, proteins and nucleic acids | |
| AU8912698A (en) | Inhibition of hiv-1 replication using d-amino acid peptides | |
| AU4120096A (en) | Production of recombinant peptides as natural hydrophobic peptide analogues | |
| AU3953197A (en) | Catechol amino acid derivatives and pharmaceutical compositions containing them | |
| NO963000D0 (en) | Improved digestibility of pharmaceutically active amino acids | |
| AU1684099A (en) | Amino acid derivatives | |
| AU3407597A (en) | Useful formulations of acid addition salt drugs | |
| AU1616901A (en) | Beryllofluoride analogues of acyl phosphate polypeptides | |
| AU8536398A (en) | Incorporation of pharmacologically active amino acid analogues into proteins | |
| AU6843498A (en) | Process for the preparation of n-(3-hydroxy-succinyl)-amino acid derivatives | |
| AU4546196A (en) | Amino acid compositions | |
| AU5337198A (en) | Production of biologically active polypeptides | |
| AU8573598A (en) | Novel azatyrosine analogues and process of preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |